Aarhus University and a number of international pharmaceutical manufacturers are joining forces in a groundbreaking, open research collaboration, ODIN (Open Discovery Innovation Network), which the Novo Nordisk Foundation supports with DKK 54.5 million. Data and results from the collaboration are made open and free to the outside world. The ambition is to utilize the collective knowledge of all the researchers participating in ODIN and in the long term create innovation for the benefit of patients, industry and society.